Egros Fabrice
Director at SNDX
- Sold, on record
- $1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Nov 18, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SNDXSyndax Pharmaceuticals IncDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale SNDXUnusualMar 1, 2021 2021
Sold 10,241 shares at $24.31 ($249k)
Egros Fabrice, Director
Sold 39% of holdings ($638k position)16,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale SNDXUnusualMay 18, 2021 +78 days
Sold 13,609 shares at $18.65 ($254k)
Egros Fabrice, Director
Sold 46% of holdings ($552k position)16,000 shares leftFiling
- 3 Form 4 sale SNDXUnusualAug 18, 2021 +92 days
Sold 15,635 shares at $15.75 ($246k)
Egros Fabrice, Director
Sold 49.4% of holdings ($498k position)16,000 shares leftFiling
- 4 Form 4 sale SNDXUnusualNov 18, 2021 +92 days
Sold 14,030 shares at $18.03 ($253k)
Egros Fabrice, Director
Sold 46.7% of holdings ($541k position)16,000 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Nov 19, 2021 | SNDX | Director | Form 4 sale | 14,030 | $253k | 46.7% | Unusual | SEC |
| Aug 18, 2021 | Aug 20, 2021 | SNDX | Director | Form 4 sale | 15,635 | $246k | 49.4% | Unusual | SEC |
| May 18, 2021 | May 20, 2021 | SNDX | Director | Form 4 sale | 13,609 | $254k | 46.0% | Unusual | SEC |
| Mar 1, 2021 | Mar 3, 2021 | SNDX | Director | Form 4 sale | 10,241 | $249k | 39.0% | Unusual | SEC |